Glen Clack News Today

Evgen Pharma PLC on Tuesday said final data from a trial of its SFX-01 therapy has shown a new formulation of the drug is safe. The Cheshire, England-based clinical stage drug development company... -Today at 05:02 am- MarketScreener

Evgen Pharma PLC (AIM:EVG) chief medical officer Dr Glen Clack takes the opportunity presented by Glioblastoma Awareness Day to speak with Thomas Warner...

Investegate announcements from Evgen Pharma PLC, Full Year Results

Investegate announcements from Evgen Pharma PLC, Grant of Options

26 April 2021 | 09:34am StockMarketWire.com - Clinical stage drug development company Evgen said had appointed Glen Clack, MD, FFPM as chief medical officer starting from 1 May 2021. Clack has over 30 years experience in oncology and translational medicine, and held various roles within AstraZeneca for almost 20 years, the company said. At 9:34am: [LON:EVG] Evgen Pharma Plc share price was 0p at 8.3p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, IS...

Evgen Appointment of Chief Medical Officer Search jobs Evgen Appointment of Chief Medical Officer Evgen (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer, inflammation and acute respiratory distress syndrome, announces that Glen Clack, MD, FFPM will be joining the Company as Chief Medical Officer effective from 1 May 2021. Dr Clack has over 30 years experience in oncology and translational medicine, and held various roles within As...